nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—Topotecan—ovarian cancer	0.269	1	CrCtD
Irinotecan—Topoisomerase Inhibitors—Topotecan—ovarian cancer	0.147	0.531	CiPCiCtD
Irinotecan—TOP1—ovarian cancer	0.0916	0.893	CbGaD
Irinotecan—colon cancer—ovarian cancer	0.0823	0.515	CtDrD
Irinotecan—breast cancer—ovarian cancer	0.0776	0.485	CtDrD
Irinotecan—Topoisomerase Inhibitors—Epirubicin—ovarian cancer	0.0674	0.244	CiPCiCtD
Irinotecan—Topoisomerase Inhibitors—Doxorubicin—ovarian cancer	0.0624	0.225	CiPCiCtD
Irinotecan—TOP1MT—Topotecan—ovarian cancer	0.0614	0.432	CbGbCtD
Irinotecan—TOP1—Topotecan—ovarian cancer	0.0352	0.248	CbGbCtD
Irinotecan—SLC22A3—Melphalan—ovarian cancer	0.011	0.0777	CbGbCtD
Irinotecan—ABCB1—ovarian cancer	0.0109	0.106	CbGaD
Irinotecan—ABCG2—Topotecan—ovarian cancer	0.00334	0.0235	CbGbCtD
Irinotecan—ABCC1—Epirubicin—ovarian cancer	0.00251	0.0176	CbGbCtD
Irinotecan—ABCC1—Paclitaxel—ovarian cancer	0.00247	0.0174	CbGbCtD
Irinotecan—ABCC2—Paclitaxel—ovarian cancer	0.00183	0.0129	CbGbCtD
Irinotecan—ABCC1—Docetaxel—ovarian cancer	0.00179	0.0126	CbGbCtD
Irinotecan—ABCC2—Carboplatin—ovarian cancer	0.00172	0.0121	CbGbCtD
Irinotecan—ABCG2—Paclitaxel—ovarian cancer	0.00165	0.0116	CbGbCtD
Irinotecan—ABCG2—Carboplatin—ovarian cancer	0.00156	0.011	CbGbCtD
Irinotecan—ABCC1—Doxorubicin—ovarian cancer	0.00133	0.00938	CbGbCtD
Irinotecan—ABCC2—Docetaxel—ovarian cancer	0.00132	0.00931	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.00122	0.0086	CbGbCtD
Irinotecan—CYP3A7—Paclitaxel—ovarian cancer	0.00122	0.0086	CbGbCtD
Irinotecan—ABCB1—Topotecan—ovarian cancer	0.00121	0.00848	CbGbCtD
Irinotecan—ABCG2—Docetaxel—ovarian cancer	0.0012	0.00842	CbGbCtD
Irinotecan—Topotecan—TOP1—ovarian cancer	0.00103	0.893	CrCbGaD
Irinotecan—ABCC2—Doxorubicin—ovarian cancer	0.000987	0.00694	CbGbCtD
Irinotecan—CYP3A5—Paclitaxel—ovarian cancer	0.000917	0.00645	CbGbCtD
Irinotecan—ABCG2—Doxorubicin—ovarian cancer	0.000892	0.00628	CbGbCtD
Irinotecan—CYP3A7—Docetaxel—ovarian cancer	0.000884	0.00622	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.000884	0.00622	CbGbCtD
Irinotecan—ABCB1—Vinorelbine—ovarian cancer	0.000849	0.00598	CbGbCtD
Irinotecan—BCHE—diaphragm—ovarian cancer	0.00081	0.0799	CbGeAlD
Irinotecan—CYP3A4—Topotecan—ovarian cancer	0.000722	0.00508	CbGbCtD
Irinotecan—CYP3A5—Docetaxel—ovarian cancer	0.000663	0.00466	CbGbCtD
Irinotecan—CYP2B6—Doxorubicin—ovarian cancer	0.000627	0.00441	CbGbCtD
Irinotecan—ABCB1—Paclitaxel—ovarian cancer	0.000597	0.0042	CbGbCtD
Irinotecan—CYP3A4—Vinorelbine—ovarian cancer	0.000509	0.00358	CbGbCtD
Irinotecan—ABCB1—Docetaxel—ovarian cancer	0.000431	0.00304	CbGbCtD
Irinotecan—CYP3A4—Paclitaxel—ovarian cancer	0.000358	0.00252	CbGbCtD
Irinotecan—TOP1MT—gonad—ovarian cancer	0.000332	0.0328	CbGeAlD
Irinotecan—ABCB1—Doxorubicin—ovarian cancer	0.000322	0.00226	CbGbCtD
Irinotecan—TOP1MT—female reproductive system—ovarian cancer	0.000296	0.0292	CbGeAlD
Irinotecan—TOP1MT—female gonad—ovarian cancer	0.00027	0.0266	CbGeAlD
Irinotecan—TOP1—myometrium—ovarian cancer	0.000268	0.0265	CbGeAlD
Irinotecan—CYP3A4—Docetaxel—ovarian cancer	0.000258	0.00182	CbGbCtD
Irinotecan—CES2—myometrium—ovarian cancer	0.000243	0.024	CbGeAlD
Irinotecan—TOP1MT—testis—ovarian cancer	0.000239	0.0236	CbGeAlD
Irinotecan—TOP1—uterine cervix—ovarian cancer	0.000209	0.0206	CbGeAlD
Irinotecan—TOP1—decidua—ovarian cancer	0.000199	0.0196	CbGeAlD
Irinotecan—CYP3A4—Doxorubicin—ovarian cancer	0.000193	0.00136	CbGbCtD
Irinotecan—CES2—uterine cervix—ovarian cancer	0.000189	0.0187	CbGeAlD
Irinotecan—TOP1—endometrium—ovarian cancer	0.000189	0.0186	CbGeAlD
Irinotecan—CES2—decidua—ovarian cancer	0.00018	0.0178	CbGeAlD
Irinotecan—TOP1—uterus—ovarian cancer	0.000174	0.0172	CbGeAlD
Irinotecan—TOP1MT—lymph node—ovarian cancer	0.000173	0.0171	CbGeAlD
Irinotecan—CES2—endometrium—ovarian cancer	0.000171	0.0169	CbGeAlD
Irinotecan—CES2—gonad—ovarian cancer	0.000159	0.0157	CbGeAlD
Irinotecan—CES2—uterus—ovarian cancer	0.000158	0.0156	CbGeAlD
Irinotecan—TOP1—bone marrow—ovarian cancer	0.000148	0.0146	CbGeAlD
Irinotecan—TOP1—female gonad—ovarian cancer	0.000142	0.014	CbGeAlD
Irinotecan—CES2—female reproductive system—ovarian cancer	0.000142	0.014	CbGeAlD
Irinotecan—TOP1—vagina—ovarian cancer	0.000141	0.014	CbGeAlD
Irinotecan—SLC22A3—myometrium—ovarian cancer	0.000139	0.0137	CbGeAlD
Irinotecan—CES2—bone marrow—ovarian cancer	0.000134	0.0132	CbGeAlD
Irinotecan—SLC22A3—embryo—ovarian cancer	0.000134	0.0132	CbGeAlD
Irinotecan—CES2—female gonad—ovarian cancer	0.000129	0.0127	CbGeAlD
Irinotecan—CES2—vagina—ovarian cancer	0.000128	0.0127	CbGeAlD
Irinotecan—TOP1—testis—ovarian cancer	0.000126	0.0125	CbGeAlD
Irinotecan—Topotecan—ABCB1—ovarian cancer	0.000123	0.106	CrCbGaD
Irinotecan—CES1—female reproductive system—ovarian cancer	0.000117	0.0115	CbGeAlD
Irinotecan—ABCC1—myometrium—ovarian cancer	0.000115	0.0113	CbGeAlD
Irinotecan—CES2—testis—ovarian cancer	0.000114	0.0113	CbGeAlD
Irinotecan—SLC22A3—uterine cervix—ovarian cancer	0.000108	0.0107	CbGeAlD
Irinotecan—CES1—female gonad—ovarian cancer	0.000106	0.0105	CbGeAlD
Irinotecan—SLCO1B1—female reproductive system—ovarian cancer	0.0001	0.0099	CbGeAlD
Irinotecan—BCHE—myometrium—ovarian cancer	9.85e-05	0.00971	CbGeAlD
Irinotecan—SLC22A3—endometrium—ovarian cancer	9.79e-05	0.00965	CbGeAlD
Irinotecan—ABCG2—myometrium—ovarian cancer	9.52e-05	0.00939	CbGeAlD
Irinotecan—ACHE—testis—ovarian cancer	9.43e-05	0.0093	CbGeAlD
Irinotecan—CES1—testis—ovarian cancer	9.43e-05	0.0093	CbGeAlD
Irinotecan—TOP1—lymph node—ovarian cancer	9.15e-05	0.00903	CbGeAlD
Irinotecan—SLC22A3—gonad—ovarian cancer	9.08e-05	0.00895	CbGeAlD
Irinotecan—ABCC1—uterine cervix—ovarian cancer	8.94e-05	0.00882	CbGeAlD
Irinotecan—ABCC1—decidua—ovarian cancer	8.52e-05	0.00841	CbGeAlD
Irinotecan—CES2—lymph node—ovarian cancer	8.3e-05	0.00819	CbGeAlD
Irinotecan—SLC22A3—female reproductive system—ovarian cancer	8.11e-05	0.008	CbGeAlD
Irinotecan—ABCC1—endometrium—ovarian cancer	8.09e-05	0.00798	CbGeAlD
Irinotecan—BCHE—uterine cervix—ovarian cancer	7.66e-05	0.00756	CbGeAlD
Irinotecan—ABCC2—female reproductive system—ovarian cancer	7.61e-05	0.00751	CbGeAlD
Irinotecan—ABCC1—uterus—ovarian cancer	7.46e-05	0.00736	CbGeAlD
Irinotecan—ABCG2—uterine cervix—ovarian cancer	7.41e-05	0.00731	CbGeAlD
Irinotecan—SLC22A3—female gonad—ovarian cancer	7.38e-05	0.00728	CbGeAlD
Irinotecan—SLC22A3—vagina—ovarian cancer	7.33e-05	0.00723	CbGeAlD
Irinotecan—ABCG2—decidua—ovarian cancer	7.06e-05	0.00696	CbGeAlD
Irinotecan—BCHE—endometrium—ovarian cancer	6.93e-05	0.00684	CbGeAlD
Irinotecan—CYP3A5—uterine cervix—ovarian cancer	6.87e-05	0.00678	CbGeAlD
Irinotecan—ACHE—lymph node—ovarian cancer	6.83e-05	0.00674	CbGeAlD
Irinotecan—CES1—lymph node—ovarian cancer	6.83e-05	0.00674	CbGeAlD
Irinotecan—ABCG2—endometrium—ovarian cancer	6.7e-05	0.00661	CbGeAlD
Irinotecan—ALB—testis—ovarian cancer	6.55e-05	0.00646	CbGeAlD
Irinotecan—SLC22A3—testis—ovarian cancer	6.54e-05	0.00645	CbGeAlD
Irinotecan—BCHE—uterus—ovarian cancer	6.39e-05	0.0063	CbGeAlD
Irinotecan—ABCG2—uterus—ovarian cancer	6.17e-05	0.00609	CbGeAlD
Irinotecan—ABCC2—testis—ovarian cancer	6.14e-05	0.00606	CbGeAlD
Irinotecan—ABCC1—female gonad—ovarian cancer	6.1e-05	0.00602	CbGeAlD
Irinotecan—ABCC1—vagina—ovarian cancer	6.06e-05	0.00598	CbGeAlD
Irinotecan—BCHE—female reproductive system—ovarian cancer	5.74e-05	0.00566	CbGeAlD
Irinotecan—CYP2B6—gonad—ovarian cancer	5.73e-05	0.00565	CbGeAlD
Irinotecan—BCHE—bone marrow—ovarian cancer	5.42e-05	0.00535	CbGeAlD
Irinotecan—ABCC1—testis—ovarian cancer	5.41e-05	0.00534	CbGeAlD
Irinotecan—ABCG2—bone marrow—ovarian cancer	5.24e-05	0.00517	CbGeAlD
Irinotecan—BCHE—vagina—ovarian cancer	5.19e-05	0.00512	CbGeAlD
Irinotecan—CYP2B6—female reproductive system—ovarian cancer	5.12e-05	0.00505	CbGeAlD
Irinotecan—ABCG2—female gonad—ovarian cancer	5.05e-05	0.00498	CbGeAlD
Irinotecan—ABCG2—vagina—ovarian cancer	5.02e-05	0.00495	CbGeAlD
Irinotecan—ALB—lymph node—ovarian cancer	4.75e-05	0.00469	CbGeAlD
Irinotecan—SLC22A3—lymph node—ovarian cancer	4.74e-05	0.00468	CbGeAlD
Irinotecan—ABCB1—myometrium—ovarian cancer	4.69e-05	0.00463	CbGeAlD
Irinotecan—CYP3A5—female gonad—ovarian cancer	4.69e-05	0.00462	CbGeAlD
Irinotecan—CYP3A5—vagina—ovarian cancer	4.66e-05	0.0046	CbGeAlD
Irinotecan—BCHE—testis—ovarian cancer	4.63e-05	0.00457	CbGeAlD
Irinotecan—CYP2B6—vagina—ovarian cancer	4.63e-05	0.00457	CbGeAlD
Irinotecan—ABCB1—embryo—ovarian cancer	4.51e-05	0.00445	CbGeAlD
Irinotecan—ABCG2—testis—ovarian cancer	4.48e-05	0.00442	CbGeAlD
Irinotecan—ABCC2—lymph node—ovarian cancer	4.45e-05	0.00439	CbGeAlD
Irinotecan—CYP2B6—testis—ovarian cancer	4.13e-05	0.00408	CbGeAlD
Irinotecan—ABCC1—lymph node—ovarian cancer	3.92e-05	0.00387	CbGeAlD
Irinotecan—CYP3A4—female reproductive system—ovarian cancer	3.87e-05	0.00381	CbGeAlD
Irinotecan—ABCB1—epithelium—ovarian cancer	3.68e-05	0.00363	CbGeAlD
Irinotecan—ABCB1—uterine cervix—ovarian cancer	3.65e-05	0.0036	CbGeAlD
Irinotecan—ABCB1—decidua—ovarian cancer	3.48e-05	0.00343	CbGeAlD
Irinotecan—BCHE—lymph node—ovarian cancer	3.36e-05	0.00331	CbGeAlD
Irinotecan—ABCB1—endometrium—ovarian cancer	3.3e-05	0.00326	CbGeAlD
Irinotecan—ABCG2—lymph node—ovarian cancer	3.25e-05	0.0032	CbGeAlD
Irinotecan—ABCB1—gonad—ovarian cancer	3.06e-05	0.00302	CbGeAlD
Irinotecan—ABCB1—uterus—ovarian cancer	3.04e-05	0.003	CbGeAlD
Irinotecan—ABCB1—female reproductive system—ovarian cancer	2.74e-05	0.0027	CbGeAlD
Irinotecan—ABCB1—bone marrow—ovarian cancer	2.58e-05	0.00255	CbGeAlD
Irinotecan—ABCB1—female gonad—ovarian cancer	2.49e-05	0.00246	CbGeAlD
Irinotecan—ABCB1—vagina—ovarian cancer	2.47e-05	0.00244	CbGeAlD
Irinotecan—ABCB1—testis—ovarian cancer	2.21e-05	0.00218	CbGeAlD
Irinotecan—Vomiting—Melphalan—ovarian cancer	1.77e-05	0.000586	CcSEcCtD
Irinotecan—Dehydration—Epirubicin—ovarian cancer	1.77e-05	0.000586	CcSEcCtD
Irinotecan—Hyponatraemia—Doxorubicin—ovarian cancer	1.76e-05	0.000586	CcSEcCtD
Irinotecan—Immune system disorder—Docetaxel—ovarian cancer	1.76e-05	0.000584	CcSEcCtD
Irinotecan—Loss of consciousness—Paclitaxel—ovarian cancer	1.76e-05	0.000584	CcSEcCtD
Irinotecan—Osteoarthritis—Doxorubicin—ovarian cancer	1.76e-05	0.000583	CcSEcCtD
Irinotecan—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	1.76e-05	0.000583	CcSEcCtD
Irinotecan—Mediastinal disorder—Docetaxel—ovarian cancer	1.76e-05	0.000583	CcSEcCtD
Irinotecan—Rash—Melphalan—ovarian cancer	1.75e-05	0.000581	CcSEcCtD
Irinotecan—Dermatitis—Melphalan—ovarian cancer	1.75e-05	0.000581	CcSEcCtD
Irinotecan—Chills—Docetaxel—ovarian cancer	1.75e-05	0.00058	CcSEcCtD
Irinotecan—Cough—Paclitaxel—ovarian cancer	1.75e-05	0.000579	CcSEcCtD
Irinotecan—Asthenia—Vinorelbine—ovarian cancer	1.74e-05	0.000578	CcSEcCtD
Irinotecan—Arrhythmia—Docetaxel—ovarian cancer	1.74e-05	0.000577	CcSEcCtD
Irinotecan—Orthostatic hypotension—Epirubicin—ovarian cancer	1.74e-05	0.000576	CcSEcCtD
Irinotecan—Hypokalaemia—Epirubicin—ovarian cancer	1.73e-05	0.000574	CcSEcCtD
Irinotecan—Hypertension—Paclitaxel—ovarian cancer	1.73e-05	0.000573	CcSEcCtD
Irinotecan—Alopecia—Docetaxel—ovarian cancer	1.72e-05	0.000571	CcSEcCtD
Irinotecan—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	1.71e-05	0.000568	CcSEcCtD
Irinotecan—Nausea—Topotecan—ovarian cancer	1.69e-05	0.000559	CcSEcCtD
Irinotecan—Discomfort—Paclitaxel—ovarian cancer	1.68e-05	0.000558	CcSEcCtD
Irinotecan—Cardiac arrest—Doxorubicin—ovarian cancer	1.67e-05	0.000555	CcSEcCtD
Irinotecan—Diarrhoea—Vinorelbine—ovarian cancer	1.66e-05	0.000551	CcSEcCtD
Irinotecan—Abdominal distension—Epirubicin—ovarian cancer	1.65e-05	0.000548	CcSEcCtD
Irinotecan—Nausea—Melphalan—ovarian cancer	1.65e-05	0.000548	CcSEcCtD
Irinotecan—Confusional state—Paclitaxel—ovarian cancer	1.65e-05	0.000546	CcSEcCtD
Irinotecan—Blood creatinine increased—Doxorubicin—ovarian cancer	1.65e-05	0.000546	CcSEcCtD
Irinotecan—Back pain—Docetaxel—ovarian cancer	1.64e-05	0.000544	CcSEcCtD
Irinotecan—Dehydration—Doxorubicin—ovarian cancer	1.63e-05	0.000542	CcSEcCtD
Irinotecan—Oedema—Paclitaxel—ovarian cancer	1.63e-05	0.000542	CcSEcCtD
Irinotecan—Anaphylactic shock—Paclitaxel—ovarian cancer	1.63e-05	0.000542	CcSEcCtD
Irinotecan—Muscle spasms—Docetaxel—ovarian cancer	1.63e-05	0.000541	CcSEcCtD
Irinotecan—Infection—Paclitaxel—ovarian cancer	1.62e-05	0.000538	CcSEcCtD
Irinotecan—Pancreatitis—Epirubicin—ovarian cancer	1.61e-05	0.000534	CcSEcCtD
Irinotecan—Shock—Paclitaxel—ovarian cancer	1.61e-05	0.000533	CcSEcCtD
Irinotecan—Dizziness—Vinorelbine—ovarian cancer	1.61e-05	0.000533	CcSEcCtD
Irinotecan—Orthostatic hypotension—Doxorubicin—ovarian cancer	1.61e-05	0.000533	CcSEcCtD
Irinotecan—Nervous system disorder—Paclitaxel—ovarian cancer	1.6e-05	0.000531	CcSEcCtD
Irinotecan—ABCB1—lymph node—ovarian cancer	1.6e-05	0.00158	CbGeAlD
Irinotecan—Hypokalaemia—Doxorubicin—ovarian cancer	1.6e-05	0.000531	CcSEcCtD
Irinotecan—Angina pectoris—Epirubicin—ovarian cancer	1.6e-05	0.000531	CcSEcCtD
Irinotecan—Thrombocytopenia—Paclitaxel—ovarian cancer	1.6e-05	0.000531	CcSEcCtD
Irinotecan—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	1.58e-05	0.000525	CcSEcCtD
Irinotecan—Hyperhidrosis—Paclitaxel—ovarian cancer	1.58e-05	0.000524	CcSEcCtD
Irinotecan—Anaemia—Docetaxel—ovarian cancer	1.57e-05	0.00052	CcSEcCtD
Irinotecan—Anorexia—Paclitaxel—ovarian cancer	1.56e-05	0.000516	CcSEcCtD
Irinotecan—Vomiting—Vinorelbine—ovarian cancer	1.54e-05	0.000512	CcSEcCtD
Irinotecan—Neutropenia—Epirubicin—ovarian cancer	1.54e-05	0.000509	CcSEcCtD
Irinotecan—Rash—Vinorelbine—ovarian cancer	1.53e-05	0.000508	CcSEcCtD
Irinotecan—Dermatitis—Vinorelbine—ovarian cancer	1.53e-05	0.000507	CcSEcCtD
Irinotecan—Abdominal distension—Doxorubicin—ovarian cancer	1.53e-05	0.000507	CcSEcCtD
Irinotecan—Hypotension—Paclitaxel—ovarian cancer	1.53e-05	0.000506	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Epirubicin—ovarian cancer	1.53e-05	0.000506	CcSEcCtD
Irinotecan—Headache—Vinorelbine—ovarian cancer	1.52e-05	0.000505	CcSEcCtD
Irinotecan—Syncope—Docetaxel—ovarian cancer	1.52e-05	0.000505	CcSEcCtD
Irinotecan—Leukopenia—Docetaxel—ovarian cancer	1.52e-05	0.000504	CcSEcCtD
Irinotecan—Loss of consciousness—Docetaxel—ovarian cancer	1.49e-05	0.000495	CcSEcCtD
Irinotecan—Pancreatitis—Doxorubicin—ovarian cancer	1.49e-05	0.000494	CcSEcCtD
Irinotecan—Weight decreased—Epirubicin—ovarian cancer	1.49e-05	0.000493	CcSEcCtD
Irinotecan—Cough—Docetaxel—ovarian cancer	1.48e-05	0.000491	CcSEcCtD
Irinotecan—Angina pectoris—Doxorubicin—ovarian cancer	1.48e-05	0.000491	CcSEcCtD
Irinotecan—Insomnia—Paclitaxel—ovarian cancer	1.48e-05	0.00049	CcSEcCtD
Irinotecan—Pneumonia—Epirubicin—ovarian cancer	1.47e-05	0.000489	CcSEcCtD
Irinotecan—Paraesthesia—Paclitaxel—ovarian cancer	1.47e-05	0.000487	CcSEcCtD
Irinotecan—Hypertension—Docetaxel—ovarian cancer	1.46e-05	0.000486	CcSEcCtD
Irinotecan—Dyspnoea—Paclitaxel—ovarian cancer	1.46e-05	0.000483	CcSEcCtD
Irinotecan—Somnolence—Paclitaxel—ovarian cancer	1.45e-05	0.000482	CcSEcCtD
Irinotecan—Nausea—Vinorelbine—ovarian cancer	1.44e-05	0.000478	CcSEcCtD
Irinotecan—Renal failure—Epirubicin—ovarian cancer	1.44e-05	0.000477	CcSEcCtD
Irinotecan—Dyspepsia—Paclitaxel—ovarian cancer	1.44e-05	0.000477	CcSEcCtD
Irinotecan—Jaundice—Epirubicin—ovarian cancer	1.43e-05	0.000473	CcSEcCtD
Irinotecan—Stomatitis—Epirubicin—ovarian cancer	1.43e-05	0.000473	CcSEcCtD
Irinotecan—Neutropenia—Doxorubicin—ovarian cancer	1.42e-05	0.000471	CcSEcCtD
Irinotecan—Decreased appetite—Paclitaxel—ovarian cancer	1.42e-05	0.000471	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Doxorubicin—ovarian cancer	1.41e-05	0.000468	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Paclitaxel—ovarian cancer	1.41e-05	0.000468	CcSEcCtD
Irinotecan—Fatigue—Paclitaxel—ovarian cancer	1.41e-05	0.000467	CcSEcCtD
Irinotecan—Sweating—Epirubicin—ovarian cancer	1.4e-05	0.000466	CcSEcCtD
Irinotecan—Pain—Paclitaxel—ovarian cancer	1.4e-05	0.000463	CcSEcCtD
Irinotecan—Constipation—Paclitaxel—ovarian cancer	1.4e-05	0.000463	CcSEcCtD
Irinotecan—Confusional state—Docetaxel—ovarian cancer	1.4e-05	0.000463	CcSEcCtD
Irinotecan—Oedema—Docetaxel—ovarian cancer	1.38e-05	0.000459	CcSEcCtD
Irinotecan—Anaphylactic shock—Docetaxel—ovarian cancer	1.38e-05	0.000459	CcSEcCtD
Irinotecan—Infection—Docetaxel—ovarian cancer	1.38e-05	0.000456	CcSEcCtD
Irinotecan—Weight decreased—Doxorubicin—ovarian cancer	1.37e-05	0.000456	CcSEcCtD
Irinotecan—Pneumonia—Doxorubicin—ovarian cancer	1.36e-05	0.000452	CcSEcCtD
Irinotecan—Shock—Docetaxel—ovarian cancer	1.36e-05	0.000452	CcSEcCtD
Irinotecan—Nervous system disorder—Docetaxel—ovarian cancer	1.36e-05	0.00045	CcSEcCtD
Irinotecan—Thrombocytopenia—Docetaxel—ovarian cancer	1.36e-05	0.00045	CcSEcCtD
Irinotecan—Feeling abnormal—Paclitaxel—ovarian cancer	1.35e-05	0.000446	CcSEcCtD
Irinotecan—Bradycardia—Epirubicin—ovarian cancer	1.34e-05	0.000444	CcSEcCtD
Irinotecan—Gastrointestinal pain—Paclitaxel—ovarian cancer	1.34e-05	0.000443	CcSEcCtD
Irinotecan—Renal failure—Doxorubicin—ovarian cancer	1.33e-05	0.000442	CcSEcCtD
Irinotecan—Haemoglobin—Epirubicin—ovarian cancer	1.32e-05	0.000438	CcSEcCtD
Irinotecan—Jaundice—Doxorubicin—ovarian cancer	1.32e-05	0.000438	CcSEcCtD
Irinotecan—Stomatitis—Doxorubicin—ovarian cancer	1.32e-05	0.000438	CcSEcCtD
Irinotecan—Anorexia—Docetaxel—ovarian cancer	1.32e-05	0.000438	CcSEcCtD
Irinotecan—Rhinitis—Epirubicin—ovarian cancer	1.32e-05	0.000437	CcSEcCtD
Irinotecan—Haemorrhage—Epirubicin—ovarian cancer	1.31e-05	0.000436	CcSEcCtD
Irinotecan—Sweating—Doxorubicin—ovarian cancer	1.3e-05	0.000431	CcSEcCtD
Irinotecan—Hypotension—Docetaxel—ovarian cancer	1.29e-05	0.000429	CcSEcCtD
Irinotecan—Connective tissue disorder—Epirubicin—ovarian cancer	1.29e-05	0.000428	CcSEcCtD
Irinotecan—Body temperature increased—Paclitaxel—ovarian cancer	1.29e-05	0.000428	CcSEcCtD
Irinotecan—Abdominal pain—Paclitaxel—ovarian cancer	1.29e-05	0.000428	CcSEcCtD
Irinotecan—Visual impairment—Epirubicin—ovarian cancer	1.27e-05	0.00042	CcSEcCtD
Irinotecan—Insomnia—Docetaxel—ovarian cancer	1.25e-05	0.000415	CcSEcCtD
Irinotecan—Paraesthesia—Docetaxel—ovarian cancer	1.24e-05	0.000412	CcSEcCtD
Irinotecan—Bradycardia—Doxorubicin—ovarian cancer	1.24e-05	0.000411	CcSEcCtD
Irinotecan—Dyspnoea—Docetaxel—ovarian cancer	1.23e-05	0.000409	CcSEcCtD
Irinotecan—Somnolence—Docetaxel—ovarian cancer	1.23e-05	0.000408	CcSEcCtD
Irinotecan—Haemoglobin—Doxorubicin—ovarian cancer	1.22e-05	0.000405	CcSEcCtD
Irinotecan—Cardiac disorder—Epirubicin—ovarian cancer	1.22e-05	0.000405	CcSEcCtD
Irinotecan—Flushing—Epirubicin—ovarian cancer	1.22e-05	0.000405	CcSEcCtD
Irinotecan—Rhinitis—Doxorubicin—ovarian cancer	1.22e-05	0.000404	CcSEcCtD
Irinotecan—Dyspepsia—Docetaxel—ovarian cancer	1.22e-05	0.000404	CcSEcCtD
Irinotecan—Haemorrhage—Doxorubicin—ovarian cancer	1.22e-05	0.000403	CcSEcCtD
Irinotecan—Decreased appetite—Docetaxel—ovarian cancer	1.2e-05	0.000399	CcSEcCtD
Irinotecan—Hypersensitivity—Paclitaxel—ovarian cancer	1.2e-05	0.000399	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Docetaxel—ovarian cancer	1.2e-05	0.000396	CcSEcCtD
Irinotecan—Connective tissue disorder—Doxorubicin—ovarian cancer	1.19e-05	0.000396	CcSEcCtD
Irinotecan—Fatigue—Docetaxel—ovarian cancer	1.19e-05	0.000396	CcSEcCtD
Irinotecan—Angiopathy—Epirubicin—ovarian cancer	1.19e-05	0.000396	CcSEcCtD
Irinotecan—Immune system disorder—Epirubicin—ovarian cancer	1.19e-05	0.000394	CcSEcCtD
Irinotecan—Mediastinal disorder—Epirubicin—ovarian cancer	1.18e-05	0.000393	CcSEcCtD
Irinotecan—Constipation—Docetaxel—ovarian cancer	1.18e-05	0.000393	CcSEcCtD
Irinotecan—Pain—Docetaxel—ovarian cancer	1.18e-05	0.000393	CcSEcCtD
Irinotecan—Chills—Epirubicin—ovarian cancer	1.18e-05	0.000391	CcSEcCtD
Irinotecan—Arrhythmia—Epirubicin—ovarian cancer	1.17e-05	0.00039	CcSEcCtD
Irinotecan—Visual impairment—Doxorubicin—ovarian cancer	1.17e-05	0.000389	CcSEcCtD
Irinotecan—Asthenia—Paclitaxel—ovarian cancer	1.17e-05	0.000389	CcSEcCtD
Irinotecan—Alopecia—Epirubicin—ovarian cancer	1.16e-05	0.000385	CcSEcCtD
Irinotecan—Feeling abnormal—Docetaxel—ovarian cancer	1.14e-05	0.000378	CcSEcCtD
Irinotecan—Gastrointestinal pain—Docetaxel—ovarian cancer	1.13e-05	0.000376	CcSEcCtD
Irinotecan—Cardiac disorder—Doxorubicin—ovarian cancer	1.13e-05	0.000374	CcSEcCtD
Irinotecan—Flushing—Doxorubicin—ovarian cancer	1.13e-05	0.000374	CcSEcCtD
Irinotecan—Flatulence—Epirubicin—ovarian cancer	1.13e-05	0.000374	CcSEcCtD
Irinotecan—Diarrhoea—Paclitaxel—ovarian cancer	1.12e-05	0.000371	CcSEcCtD
Irinotecan—Back pain—Epirubicin—ovarian cancer	1.11e-05	0.000367	CcSEcCtD
Irinotecan—Angiopathy—Doxorubicin—ovarian cancer	1.1e-05	0.000366	CcSEcCtD
Irinotecan—Muscle spasms—Epirubicin—ovarian cancer	1.1e-05	0.000365	CcSEcCtD
Irinotecan—Immune system disorder—Doxorubicin—ovarian cancer	1.1e-05	0.000364	CcSEcCtD
Irinotecan—Mediastinal disorder—Doxorubicin—ovarian cancer	1.1e-05	0.000364	CcSEcCtD
Irinotecan—Body temperature increased—Docetaxel—ovarian cancer	1.09e-05	0.000363	CcSEcCtD
Irinotecan—Abdominal pain—Docetaxel—ovarian cancer	1.09e-05	0.000363	CcSEcCtD
Irinotecan—Chills—Doxorubicin—ovarian cancer	1.09e-05	0.000362	CcSEcCtD
Irinotecan—Arrhythmia—Doxorubicin—ovarian cancer	1.09e-05	0.00036	CcSEcCtD
Irinotecan—Dizziness—Paclitaxel—ovarian cancer	1.08e-05	0.000358	CcSEcCtD
Irinotecan—Alopecia—Doxorubicin—ovarian cancer	1.07e-05	0.000356	CcSEcCtD
Irinotecan—Ill-defined disorder—Epirubicin—ovarian cancer	1.06e-05	0.000352	CcSEcCtD
Irinotecan—Anaemia—Epirubicin—ovarian cancer	1.06e-05	0.000351	CcSEcCtD
Irinotecan—Flatulence—Doxorubicin—ovarian cancer	1.04e-05	0.000346	CcSEcCtD
Irinotecan—Vomiting—Paclitaxel—ovarian cancer	1.04e-05	0.000345	CcSEcCtD
Irinotecan—Malaise—Epirubicin—ovarian cancer	1.03e-05	0.000342	CcSEcCtD
Irinotecan—Rash—Paclitaxel—ovarian cancer	1.03e-05	0.000342	CcSEcCtD
Irinotecan—Dermatitis—Paclitaxel—ovarian cancer	1.03e-05	0.000341	CcSEcCtD
Irinotecan—Vertigo—Epirubicin—ovarian cancer	1.03e-05	0.000341	CcSEcCtD
Irinotecan—Syncope—Epirubicin—ovarian cancer	1.03e-05	0.00034	CcSEcCtD
Irinotecan—Leukopenia—Epirubicin—ovarian cancer	1.02e-05	0.00034	CcSEcCtD
Irinotecan—Back pain—Doxorubicin—ovarian cancer	1.02e-05	0.00034	CcSEcCtD
Irinotecan—Headache—Paclitaxel—ovarian cancer	1.02e-05	0.000339	CcSEcCtD
Irinotecan—Hypersensitivity—Docetaxel—ovarian cancer	1.02e-05	0.000338	CcSEcCtD
Irinotecan—Muscle spasms—Doxorubicin—ovarian cancer	1.02e-05	0.000338	CcSEcCtD
Irinotecan—Loss of consciousness—Epirubicin—ovarian cancer	1.01e-05	0.000334	CcSEcCtD
Irinotecan—Cough—Epirubicin—ovarian cancer	9.98e-06	0.000331	CcSEcCtD
Irinotecan—Asthenia—Docetaxel—ovarian cancer	9.93e-06	0.00033	CcSEcCtD
Irinotecan—Hypertension—Epirubicin—ovarian cancer	9.88e-06	0.000328	CcSEcCtD
Irinotecan—Ill-defined disorder—Doxorubicin—ovarian cancer	9.82e-06	0.000326	CcSEcCtD
Irinotecan—Anaemia—Doxorubicin—ovarian cancer	9.78e-06	0.000325	CcSEcCtD
Irinotecan—Nausea—Paclitaxel—ovarian cancer	9.7e-06	0.000322	CcSEcCtD
Irinotecan—Discomfort—Epirubicin—ovarian cancer	9.62e-06	0.000319	CcSEcCtD
Irinotecan—Malaise—Doxorubicin—ovarian cancer	9.55e-06	0.000317	CcSEcCtD
Irinotecan—Vertigo—Doxorubicin—ovarian cancer	9.51e-06	0.000316	CcSEcCtD
Irinotecan—Syncope—Doxorubicin—ovarian cancer	9.49e-06	0.000315	CcSEcCtD
Irinotecan—Leukopenia—Doxorubicin—ovarian cancer	9.48e-06	0.000314	CcSEcCtD
Irinotecan—Diarrhoea—Docetaxel—ovarian cancer	9.47e-06	0.000314	CcSEcCtD
Irinotecan—Confusional state—Epirubicin—ovarian cancer	9.41e-06	0.000312	CcSEcCtD
Irinotecan—Oedema—Epirubicin—ovarian cancer	9.34e-06	0.00031	CcSEcCtD
Irinotecan—Anaphylactic shock—Epirubicin—ovarian cancer	9.34e-06	0.00031	CcSEcCtD
Irinotecan—Loss of consciousness—Doxorubicin—ovarian cancer	9.3e-06	0.000309	CcSEcCtD
Irinotecan—Infection—Epirubicin—ovarian cancer	9.28e-06	0.000308	CcSEcCtD
Irinotecan—Cough—Doxorubicin—ovarian cancer	9.24e-06	0.000306	CcSEcCtD
Irinotecan—Shock—Epirubicin—ovarian cancer	9.19e-06	0.000305	CcSEcCtD
Irinotecan—Nervous system disorder—Epirubicin—ovarian cancer	9.16e-06	0.000304	CcSEcCtD
Irinotecan—Dizziness—Docetaxel—ovarian cancer	9.15e-06	0.000304	CcSEcCtD
Irinotecan—Thrombocytopenia—Epirubicin—ovarian cancer	9.14e-06	0.000303	CcSEcCtD
Irinotecan—Hypertension—Doxorubicin—ovarian cancer	9.14e-06	0.000303	CcSEcCtD
Irinotecan—Hyperhidrosis—Epirubicin—ovarian cancer	9.03e-06	0.000299	CcSEcCtD
Irinotecan—Discomfort—Doxorubicin—ovarian cancer	8.9e-06	0.000295	CcSEcCtD
Irinotecan—Anorexia—Epirubicin—ovarian cancer	8.9e-06	0.000295	CcSEcCtD
Irinotecan—Vomiting—Docetaxel—ovarian cancer	8.8e-06	0.000292	CcSEcCtD
Irinotecan—Rash—Docetaxel—ovarian cancer	8.73e-06	0.00029	CcSEcCtD
Irinotecan—Hypotension—Epirubicin—ovarian cancer	8.72e-06	0.000289	CcSEcCtD
Irinotecan—Dermatitis—Docetaxel—ovarian cancer	8.72e-06	0.000289	CcSEcCtD
Irinotecan—Confusional state—Doxorubicin—ovarian cancer	8.71e-06	0.000289	CcSEcCtD
Irinotecan—Headache—Docetaxel—ovarian cancer	8.67e-06	0.000288	CcSEcCtD
Irinotecan—Anaphylactic shock—Doxorubicin—ovarian cancer	8.64e-06	0.000287	CcSEcCtD
Irinotecan—Oedema—Doxorubicin—ovarian cancer	8.64e-06	0.000287	CcSEcCtD
Irinotecan—Infection—Doxorubicin—ovarian cancer	8.58e-06	0.000285	CcSEcCtD
Irinotecan—Shock—Doxorubicin—ovarian cancer	8.5e-06	0.000282	CcSEcCtD
Irinotecan—Nervous system disorder—Doxorubicin—ovarian cancer	8.47e-06	0.000281	CcSEcCtD
Irinotecan—Thrombocytopenia—Doxorubicin—ovarian cancer	8.46e-06	0.000281	CcSEcCtD
Irinotecan—Insomnia—Epirubicin—ovarian cancer	8.44e-06	0.00028	CcSEcCtD
Irinotecan—Paraesthesia—Epirubicin—ovarian cancer	8.38e-06	0.000278	CcSEcCtD
Irinotecan—Hyperhidrosis—Doxorubicin—ovarian cancer	8.35e-06	0.000277	CcSEcCtD
Irinotecan—Dyspnoea—Epirubicin—ovarian cancer	8.32e-06	0.000276	CcSEcCtD
Irinotecan—Somnolence—Epirubicin—ovarian cancer	8.3e-06	0.000275	CcSEcCtD
Irinotecan—Anorexia—Doxorubicin—ovarian cancer	8.23e-06	0.000273	CcSEcCtD
Irinotecan—Nausea—Docetaxel—ovarian cancer	8.22e-06	0.000273	CcSEcCtD
Irinotecan—Dyspepsia—Epirubicin—ovarian cancer	8.22e-06	0.000273	CcSEcCtD
Irinotecan—Decreased appetite—Epirubicin—ovarian cancer	8.12e-06	0.000269	CcSEcCtD
Irinotecan—Hypotension—Doxorubicin—ovarian cancer	8.07e-06	0.000268	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Epirubicin—ovarian cancer	8.06e-06	0.000267	CcSEcCtD
Irinotecan—Fatigue—Epirubicin—ovarian cancer	8.05e-06	0.000267	CcSEcCtD
Irinotecan—Constipation—Epirubicin—ovarian cancer	7.98e-06	0.000265	CcSEcCtD
Irinotecan—Pain—Epirubicin—ovarian cancer	7.98e-06	0.000265	CcSEcCtD
Irinotecan—Insomnia—Doxorubicin—ovarian cancer	7.81e-06	0.000259	CcSEcCtD
Irinotecan—Paraesthesia—Doxorubicin—ovarian cancer	7.76e-06	0.000257	CcSEcCtD
Irinotecan—Dyspnoea—Doxorubicin—ovarian cancer	7.7e-06	0.000256	CcSEcCtD
Irinotecan—Feeling abnormal—Epirubicin—ovarian cancer	7.69e-06	0.000255	CcSEcCtD
Irinotecan—Somnolence—Doxorubicin—ovarian cancer	7.68e-06	0.000255	CcSEcCtD
Irinotecan—Gastrointestinal pain—Epirubicin—ovarian cancer	7.63e-06	0.000253	CcSEcCtD
Irinotecan—Dyspepsia—Doxorubicin—ovarian cancer	7.6e-06	0.000252	CcSEcCtD
Irinotecan—Decreased appetite—Doxorubicin—ovarian cancer	7.51e-06	0.000249	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Doxorubicin—ovarian cancer	7.46e-06	0.000247	CcSEcCtD
Irinotecan—Fatigue—Doxorubicin—ovarian cancer	7.45e-06	0.000247	CcSEcCtD
Irinotecan—Pain—Doxorubicin—ovarian cancer	7.39e-06	0.000245	CcSEcCtD
Irinotecan—Constipation—Doxorubicin—ovarian cancer	7.39e-06	0.000245	CcSEcCtD
Irinotecan—Body temperature increased—Epirubicin—ovarian cancer	7.38e-06	0.000245	CcSEcCtD
Irinotecan—Abdominal pain—Epirubicin—ovarian cancer	7.38e-06	0.000245	CcSEcCtD
Irinotecan—Feeling abnormal—Doxorubicin—ovarian cancer	7.12e-06	0.000236	CcSEcCtD
Irinotecan—Gastrointestinal pain—Doxorubicin—ovarian cancer	7.06e-06	0.000234	CcSEcCtD
Irinotecan—Hypersensitivity—Epirubicin—ovarian cancer	6.88e-06	0.000228	CcSEcCtD
Irinotecan—Body temperature increased—Doxorubicin—ovarian cancer	6.83e-06	0.000227	CcSEcCtD
Irinotecan—Abdominal pain—Doxorubicin—ovarian cancer	6.83e-06	0.000227	CcSEcCtD
Irinotecan—Asthenia—Epirubicin—ovarian cancer	6.7e-06	0.000222	CcSEcCtD
Irinotecan—Diarrhoea—Epirubicin—ovarian cancer	6.39e-06	0.000212	CcSEcCtD
Irinotecan—Hypersensitivity—Doxorubicin—ovarian cancer	6.36e-06	0.000211	CcSEcCtD
Irinotecan—Asthenia—Doxorubicin—ovarian cancer	6.2e-06	0.000206	CcSEcCtD
Irinotecan—Dizziness—Epirubicin—ovarian cancer	6.17e-06	0.000205	CcSEcCtD
Irinotecan—Vomiting—Epirubicin—ovarian cancer	5.94e-06	0.000197	CcSEcCtD
Irinotecan—Diarrhoea—Doxorubicin—ovarian cancer	5.91e-06	0.000196	CcSEcCtD
Irinotecan—Rash—Epirubicin—ovarian cancer	5.89e-06	0.000195	CcSEcCtD
Irinotecan—Dermatitis—Epirubicin—ovarian cancer	5.88e-06	0.000195	CcSEcCtD
Irinotecan—Headache—Epirubicin—ovarian cancer	5.85e-06	0.000194	CcSEcCtD
Irinotecan—Dizziness—Doxorubicin—ovarian cancer	5.71e-06	0.00019	CcSEcCtD
Irinotecan—Nausea—Epirubicin—ovarian cancer	5.55e-06	0.000184	CcSEcCtD
Irinotecan—Vomiting—Doxorubicin—ovarian cancer	5.49e-06	0.000182	CcSEcCtD
Irinotecan—Rash—Doxorubicin—ovarian cancer	5.45e-06	0.000181	CcSEcCtD
Irinotecan—Dermatitis—Doxorubicin—ovarian cancer	5.44e-06	0.000181	CcSEcCtD
Irinotecan—Headache—Doxorubicin—ovarian cancer	5.41e-06	0.00018	CcSEcCtD
Irinotecan—Nausea—Doxorubicin—ovarian cancer	5.13e-06	0.00017	CcSEcCtD
Irinotecan—BCHE—Neuronal System—HRAS—ovarian cancer	1.93e-06	0.000221	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—SLC2A1—ovarian cancer	1.92e-06	0.00022	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CYP1B1—ovarian cancer	1.89e-06	0.000217	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.88e-06	0.000216	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PPP2R1A—ovarian cancer	1.88e-06	0.000216	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—FASN—ovarian cancer	1.87e-06	0.000215	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.87e-06	0.000215	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—FASN—ovarian cancer	1.86e-06	0.000213	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.85e-06	0.000212	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—BRIP1—ovarian cancer	1.85e-06	0.000212	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.85e-06	0.000212	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CYP1B1—ovarian cancer	1.84e-06	0.000211	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—SLC5A5—ovarian cancer	1.84e-06	0.000211	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—SLC5A5—ovarian cancer	1.83e-06	0.000209	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—CXCL8—ovarian cancer	1.8e-06	0.000206	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	1.79e-06	0.000205	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PPP2R1A—ovarian cancer	1.78e-06	0.000205	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PPP2R1A—ovarian cancer	1.78e-06	0.000205	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—SLC2A1—ovarian cancer	1.78e-06	0.000204	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.78e-06	0.000204	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—SLC2A1—ovarian cancer	1.77e-06	0.000202	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.76e-06	0.000202	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—CAV1—ovarian cancer	1.76e-06	0.000201	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—ABCB1—ovarian cancer	1.75e-06	0.0002	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PPP2R1A—ovarian cancer	1.72e-06	0.000197	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—TYMS—ovarian cancer	1.72e-06	0.000197	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.71e-06	0.000196	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CYP1B1—ovarian cancer	1.71e-06	0.000196	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—CAV1—ovarian cancer	1.69e-06	0.000194	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	1.69e-06	0.000194	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CYP1B1—ovarian cancer	1.69e-06	0.000194	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—YAP1—ovarian cancer	1.69e-06	0.000193	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PPP2R1A—ovarian cancer	1.68e-06	0.000192	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.67e-06	0.000191	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.67e-06	0.000191	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—CTNNB1—ovarian cancer	1.66e-06	0.00019	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—ABCB1—ovarian cancer	1.66e-06	0.00019	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—ABCB1—ovarian cancer	1.66e-06	0.00019	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—YAP1—ovarian cancer	1.65e-06	0.000189	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PPP2R1A—ovarian cancer	1.64e-06	0.000187	CbGpPWpGaD
Irinotecan—ABCC1—Disease—TERT—ovarian cancer	1.63e-06	0.000187	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—TYMS—ovarian cancer	1.63e-06	0.000187	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—TYMS—ovarian cancer	1.63e-06	0.000187	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.63e-06	0.000187	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.62e-06	0.000186	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	1.61e-06	0.000185	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—CXCL8—ovarian cancer	1.6e-06	0.000184	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PIK3CG—ovarian cancer	1.6e-06	0.000183	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—ABCB1—ovarian cancer	1.6e-06	0.000183	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.59e-06	0.000182	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.59e-06	0.000182	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—TYMS—ovarian cancer	1.57e-06	0.00018	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—ABCB1—ovarian cancer	1.56e-06	0.000179	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PIK3CG—ovarian cancer	1.54e-06	0.000177	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.54e-06	0.000177	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—TYMS—ovarian cancer	1.53e-06	0.000175	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ABCB1—ovarian cancer	1.52e-06	0.000174	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PPP2R1A—ovarian cancer	1.51e-06	0.000174	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CAV1—ovarian cancer	1.51e-06	0.000173	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PPP2R1A—ovarian cancer	1.5e-06	0.000172	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.5e-06	0.000172	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—TYMS—ovarian cancer	1.49e-06	0.000171	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—CTNNB1—ovarian cancer	1.48e-06	0.00017	CbGpPWpGaD
Irinotecan—ABCC1—Disease—IL6ST—ovarian cancer	1.43e-06	0.000164	CbGpPWpGaD
Irinotecan—ALB—Metabolism—YAP1—ovarian cancer	1.42e-06	0.000163	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ABCB1—ovarian cancer	1.41e-06	0.000161	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PIK3CD—ovarian cancer	1.41e-06	0.000161	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.4e-06	0.000161	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	1.4e-06	0.00016	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ABCB1—ovarian cancer	1.39e-06	0.00016	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—CAV1—ovarian cancer	1.38e-06	0.000158	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—TYMS—ovarian cancer	1.38e-06	0.000158	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.38e-06	0.000158	CbGpPWpGaD
Irinotecan—ABCC1—Disease—APC—ovarian cancer	1.38e-06	0.000158	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—FASN—ovarian cancer	1.37e-06	0.000157	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—TYMS—ovarian cancer	1.37e-06	0.000157	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PIK3CD—ovarian cancer	1.36e-06	0.000155	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—SLC5A5—ovarian cancer	1.35e-06	0.000155	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—FASN—ovarian cancer	1.34e-06	0.000154	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.33e-06	0.000153	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—SLC5A5—ovarian cancer	1.32e-06	0.000151	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.32e-06	0.000151	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—CAV1—ovarian cancer	1.31e-06	0.00015	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—CAV1—ovarian cancer	1.31e-06	0.00015	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYTB—ovarian cancer	1.31e-06	0.00015	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—SLC2A1—ovarian cancer	1.31e-06	0.00015	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—SLC2A1—ovarian cancer	1.28e-06	0.000146	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CAV1—ovarian cancer	1.26e-06	0.000145	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CG—ovarian cancer	1.26e-06	0.000144	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.25e-06	0.000144	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CYP1B1—ovarian cancer	1.25e-06	0.000143	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—YAP1—ovarian cancer	1.24e-06	0.000142	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.23e-06	0.000141	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CAV1—ovarian cancer	1.23e-06	0.000141	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PIK3CB—ovarian cancer	1.23e-06	0.00014	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CYP1B1—ovarian cancer	1.22e-06	0.00014	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PIK3CD—ovarian cancer	1.21e-06	0.000139	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.21e-06	0.000138	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CAV1—ovarian cancer	1.2e-06	0.000138	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CG—ovarian cancer	1.19e-06	0.000137	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CG—ovarian cancer	1.19e-06	0.000137	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PIK3CB—ovarian cancer	1.18e-06	0.000135	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.18e-06	0.000135	CbGpPWpGaD
Irinotecan—ALB—Metabolism—FASN—ovarian cancer	1.16e-06	0.000133	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CG—ovarian cancer	1.15e-06	0.000132	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.15e-06	0.000132	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.14e-06	0.000131	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.14e-06	0.000131	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	1.14e-06	0.000131	CbGpPWpGaD
Irinotecan—ALB—Metabolism—SLC5A5—ovarian cancer	1.14e-06	0.00013	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.12e-06	0.000129	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CG—ovarian cancer	1.12e-06	0.000129	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CAV1—ovarian cancer	1.11e-06	0.000128	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	1.11e-06	0.000127	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CD—ovarian cancer	1.11e-06	0.000127	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CAV1—ovarian cancer	1.1e-06	0.000126	CbGpPWpGaD
Irinotecan—ALB—Metabolism—SLC2A1—ovarian cancer	1.1e-06	0.000126	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	1.09e-06	0.000125	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—IL2—ovarian cancer	1.09e-06	0.000124	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	1.09e-06	0.000124	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.08e-06	0.000123	CbGpPWpGaD
Irinotecan—ABCC1—Disease—ERBB2—ovarian cancer	1.07e-06	0.000122	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PTEN—ovarian cancer	1.06e-06	0.000121	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PIK3CB—ovarian cancer	1.05e-06	0.000121	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MTOR—ovarian cancer	1.05e-06	0.000121	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP1B1—ovarian cancer	1.05e-06	0.000121	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CD—ovarian cancer	1.05e-06	0.00012	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CD—ovarian cancer	1.05e-06	0.00012	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ABCB1—ovarian cancer	1.03e-06	0.000118	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—FASN—ovarian cancer	1.01e-06	0.000116	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CG—ovarian cancer	1.01e-06	0.000116	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CD—ovarian cancer	1.01e-06	0.000116	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—TYMS—ovarian cancer	1.01e-06	0.000116	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ABCB1—ovarian cancer	1.01e-06	0.000115	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CG—ovarian cancer	1e-06	0.000115	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SLC5A5—ovarian cancer	9.97e-07	0.000114	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—TYMS—ovarian cancer	9.89e-07	0.000113	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CDKN1B—ovarian cancer	9.89e-07	0.000113	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CD—ovarian cancer	9.87e-07	0.000113	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CB—ovarian cancer	9.65e-07	0.000111	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SLC2A1—ovarian cancer	9.63e-07	0.00011	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	9.62e-07	0.00011	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PPP2R1A—ovarian cancer	9.34e-07	0.000107	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CTNNB1—ovarian cancer	9.34e-07	0.000107	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	9.3e-07	0.000107	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP1B1—ovarian cancer	9.23e-07	0.000106	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—VEGFA—ovarian cancer	9.23e-07	0.000106	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CB—ovarian cancer	9.15e-07	0.000105	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CB—ovarian cancer	9.15e-07	0.000105	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—NRAS—ovarian cancer	9.11e-07	0.000104	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTEN—ovarian cancer	9.11e-07	0.000104	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CD—ovarian cancer	8.91e-07	0.000102	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CD—ovarian cancer	8.83e-07	0.000101	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CB—ovarian cancer	8.83e-07	0.000101	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—MAPK3—ovarian cancer	8.73e-07	0.0001	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ABCB1—ovarian cancer	8.68e-07	9.94e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CB—ovarian cancer	8.61e-07	9.86e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—TYMS—ovarian cancer	8.52e-07	9.77e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	8.39e-07	9.61e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTEN—ovarian cancer	8.34e-07	9.55e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—MAPK1—ovarian cancer	8.3e-07	9.52e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PPP2R1A—ovarian cancer	8.19e-07	9.38e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CAV1—ovarian cancer	8.16e-07	9.35e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—STAT3—ovarian cancer	8.15e-07	9.33e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—NRAS—ovarian cancer	8.13e-07	9.31e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CAV1—ovarian cancer	7.97e-07	9.14e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTEN—ovarian cancer	7.91e-07	9.06e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTEN—ovarian cancer	7.91e-07	9.06e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—KRAS—ovarian cancer	7.84e-07	8.99e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MAPK3—ovarian cancer	7.78e-07	8.92e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CB—ovarian cancer	7.77e-07	8.9e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CB—ovarian cancer	7.7e-07	8.82e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—YAP1—ovarian cancer	7.66e-07	8.78e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTEN—ovarian cancer	7.63e-07	8.74e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MYC—ovarian cancer	7.57e-07	8.67e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PIK3CA—ovarian cancer	7.47e-07	8.56e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—TYMS—ovarian cancer	7.47e-07	8.56e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTEN—ovarian cancer	7.44e-07	8.52e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CG—ovarian cancer	7.43e-07	8.51e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MAPK1—ovarian cancer	7.4e-07	8.49e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—EGFR—ovarian cancer	7.4e-07	8.48e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CG—ovarian cancer	7.26e-07	8.32e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTEN—ovarian cancer	7.25e-07	8.31e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PIK3CA—ovarian cancer	7.21e-07	8.26e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—KRAS—ovarian cancer	6.99e-07	8.01e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TP53—ovarian cancer	6.97e-07	7.99e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CAV1—ovarian cancer	6.87e-07	7.87e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTEN—ovarian cancer	6.71e-07	7.69e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—HRAS—ovarian cancer	6.67e-07	7.64e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTEN—ovarian cancer	6.65e-07	7.62e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.56e-07	7.52e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CD—ovarian cancer	6.53e-07	7.49e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PIK3CA—ovarian cancer	6.43e-07	7.36e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CD—ovarian cancer	6.38e-07	7.32e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CG—ovarian cancer	6.25e-07	7.17e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—FASN—ovarian cancer	6.25e-07	7.16e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC5A5—ovarian cancer	6.14e-07	7.04e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—AKT1—ovarian cancer	6.1e-07	6.99e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CAV1—ovarian cancer	6.02e-07	6.89e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HRAS—ovarian cancer	5.94e-07	6.81e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC2A1—ovarian cancer	5.93e-07	6.8e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—AKT1—ovarian cancer	5.89e-07	6.75e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CA—ovarian cancer	5.88e-07	6.74e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CB—ovarian cancer	5.69e-07	6.52e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—IL6—ovarian cancer	5.69e-07	6.52e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP1B1—ovarian cancer	5.69e-07	6.52e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CA—ovarian cancer	5.58e-07	6.39e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CA—ovarian cancer	5.58e-07	6.39e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CB—ovarian cancer	5.56e-07	6.38e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CD—ovarian cancer	5.5e-07	6.3e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CG—ovarian cancer	5.48e-07	6.28e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CA—ovarian cancer	5.38e-07	6.17e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—AKT1—ovarian cancer	5.25e-07	6.01e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CA—ovarian cancer	5.25e-07	6.01e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	5.11e-07	5.86e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	5.04e-07	5.78e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTEN—ovarian cancer	4.92e-07	5.64e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CD—ovarian cancer	4.82e-07	5.52e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTEN—ovarian cancer	4.81e-07	5.51e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—AKT1—ovarian cancer	4.8e-07	5.51e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CB—ovarian cancer	4.79e-07	5.49e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CA—ovarian cancer	4.73e-07	5.43e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CA—ovarian cancer	4.69e-07	5.38e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ABCB1—ovarian cancer	4.68e-07	5.37e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—TYMS—ovarian cancer	4.6e-07	5.27e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—AKT1—ovarian cancer	4.56e-07	5.22e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—AKT1—ovarian cancer	4.56e-07	5.22e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—AKT1—ovarian cancer	4.4e-07	5.04e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—AKT1—ovarian cancer	4.29e-07	4.91e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CB—ovarian cancer	4.2e-07	4.81e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—AKT1—ovarian cancer	4.18e-07	4.79e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTEN—ovarian cancer	4.14e-07	4.75e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—AKT1—ovarian cancer	3.87e-07	4.43e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—AKT1—ovarian cancer	3.83e-07	4.39e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CAV1—ovarian cancer	3.71e-07	4.25e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTEN—ovarian cancer	3.63e-07	4.16e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CA—ovarian cancer	3.47e-07	3.98e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CA—ovarian cancer	3.39e-07	3.89e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3.38e-07	3.87e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.97e-07	3.4e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CA—ovarian cancer	2.92e-07	3.35e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—AKT1—ovarian cancer	2.84e-07	3.25e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—AKT1—ovarian cancer	2.77e-07	3.18e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.59e-07	2.96e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CA—ovarian cancer	2.56e-07	2.93e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—AKT1—ovarian cancer	2.39e-07	2.74e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTEN—ovarian cancer	2.24e-07	2.56e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—AKT1—ovarian cancer	2.09e-07	2.4e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.58e-07	1.81e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AKT1—ovarian cancer	1.29e-07	1.48e-05	CbGpPWpGaD
